FIT screening

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.

Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.

Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website www.fitscreening.eu/patients

 

 

Please select your country. This will keep you up to date with your country-specific information.

Sentimag – Sienna+

  • Best practice SLNB for more patients,
    at any hospital, at any time
  • As effective as the radiotracer, as easy as blue dye
  • The magnetic way to detect sentinel nodes

Documents

All
  • All
  • Brochure
  • Literature
Documents

Sentimag / Sienna+ – Magnetic lymph node localisation

Many treatments for early-stage cancer involve ‘sentinel lymph node biopsy’, or SLNB. This method, which identifies the lymph nodes with the highest potential for harbouring metastases, helps to determine the nodal stage of the cancer and make informed decisions for surgery and subsequent treatment.

Standard SLNB uses radioisotopes for sentinel node localisation. We offer an effective clinical solution that uses safe magnetic fields instead. This eliminates concerns related to the safety, workflow and availability associated with ionising radiation. Best practice SLNB is now possible everywhere, with no time restrictions.

Our system consists of the Sentimag® probe and the Sienna+® magnetic tracer. First, the tracer is injected into the interstitial tissue to provide a traceable signal. Next, using the Sentimag® probe, you locate the sentinel lymph nodes to determine how far the cancer has spread.

 

Sienna+ – An effective clinical solution

  • Perform best practice SLNB in any clinical setting
  • Eliminate issues with radioactive materials; reach equivalent clinical outcomes
  • As a surgeon, organise and manage the SLNB procedure to suit your needs
  • Inject the tracer at the best moment, up to seven days in advance
  • No evidence of anaphylaxis with interstitial tracer injection
  • Sentimag® and Sienna+® are CE-approved for SLN localisation

 

Endomag®, Sentimag®, Magseed® and Sienna+® are registered European Community Trademarks of Endomagnetics Ltd. www.endomag.com.

Oncology

Sentinel node biopsy procedure

Sentinel node biopsy procedure

Video: Sienna+ tracer

Video: Sienna+ tracer

Video: Proximity-based detection

Video: Proximity-based detection

Video: Magnetic SLN localisation

Video: Magnetic SLN localisation

Clinical results Breast Cancer

Clinical results Breast Cancer

Clinical results Colorectal Cancer

Clinical results Colorectal Cancer

Clinical results Endometrial Cancer

Clinical results Endometrial Cancer

Clinical results Prostate Cancer

Clinical results Prostate Cancer

Publications

Publications

Please see our publication list

Contact


oncology@sysmex-europe.com
Bornbarch 1
22848 Norderstedt
Germany

Create Pdf
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
Explore our microsite
See our collection